Literature DB >> 31104830

Burosumab treatment of children with X-linked hypophosphataemic rickets.

Rebecca J Gordon1, Michael A Levine2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31104830     DOI: 10.1016/S0140-6736(19)31054-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

2.  Effects of Active Vitamin D or FGF23 Antibody on Hyp Mice Dentoalveolar Tissues.

Authors:  E J Lira Dos Santos; M B Chavez; M H Tan; F F Mohamed; T N Kolli; B L Foster; E S Liu
Journal:  J Dent Res       Date:  2021-04-27       Impact factor: 6.116

Review 3.  Burosumab for Pediatric X-Linked Hypophosphatemia.

Authors:  Erik A Imel
Journal:  Curr Osteoporos Rep       Date:  2021-05-10       Impact factor: 5.163

4.  Hypophosphataemic Rickets Secondary to Raine Syndrome: A Review of the Literature and Case Reports of Three Paediatric Patients' Dental Management.

Authors:  Lorna Hirst; Gehan Abou-Ameira; Simon Critchlow
Journal:  Case Rep Pediatr       Date:  2021-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.